- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02569840
Amino Acid Feed Children's Study
An Evaluation of the Tolerance and Acceptability of Neocate Junior an Amino Acid Based Formula for Children
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Dietary management of Cows' Milk Allergy (CMA) involves avoiding cow's milk protein in the diet, whilst ensuring that an adequate nutritional intake is achieved with suitable alternative foods or prescribable feeds. A number of studies and clinical insights indicate that CMA is persisting longer than infancy, into later childhood and becoming more complex. If a child has CMA, eliminating the offending allergens whilst maintaining an intake of food that meets their nutritional requirements for growth and development is challenging due to the significant nutritional contribution these foods make to a child's diet, particularly milk and dairy products. This supports the need for alternatives to cow's milk to be available for children >1year of age to help meet their nutritional needs. Aminoacid based feeds are already widely used in clinical practice to meet this need. A new nutritionally complete amino acid based powdered feed for the dietary management of CMA, or other conditions where an amino acid based is recommended, in children aged 1-10yrs old, has been developed.
This study is to support the use of this new amino acid based feed in clinical practice. The study will evaluate the tolerance and acceptability of the amino acid based powdered feed in 20 children aged 1-10yrs of age receiving or requiring an amino acid based feed for the dietary management of CMA and food allergy associated conditions, over 4 weeks. The primary outcome will be gastrointestinal tolerance, with secondary outcomes of compliance, acceptability, nutrient intake and anthropometry.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Male or female
- Age 1-10 years
- Currently using or requiring an amino acid based feed
- Expected to receive at least 30% of their energy intake from the study product
- Written informed consent from parents / carer
Exclusion Criteria:
- Parenteral nutrition contributing more than 70% of total energy intake
- Children with major hepatic or renal dysfunction
- Participation in other studies within 2 weeks prior to entry of this study
- Investigator concern around willingness/ability of parent/carer to comply with protocol requirements
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Otro: Amino Acid Feed
An amino acid based multi-nutrient powdered feed
|
Each child will receive the amino acid based feed for a period of up to 4 weeks (28 days).
The feed prescription will be determined on an individual basis by the Dietitian responsible for the child's nutritional management.
The child will take the feed orally or via a pre-existing naso-gastric, gastrostomy or jejunostomy tube.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Gastro intestinal tolerance questionnaire
Periodo de tiempo: 4 weeks
|
Gastro-intestinal tolerance will be recorded at baseline and on days 1, 2, 3 and 7 of week 1 of the study.
During weeks 2 and 3 tolerance will be recorded once at the end of each week on days 14 and 21.
During week 4, tolerance will be recorded on days 26, 27 and 28.
Tolerance will be recorded using a standardised gastro-intestinal tolerance questionnaire, to be completed by the parents/carer
|
4 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Compliance with feed prescription (amount prescribed versus consumed)
Periodo de tiempo: 4 weeks
|
Compliance with feed prescription will be assessed daily throughout the study by recording how much feed was received, to be recorded by the parents/carer.
The amount prescribed by the Dietitian will be recorded at the start of the study, and any changes to this prescription also noted
|
4 weeks
|
Product acceptability questionnaire
Periodo de tiempo: 4 weeks
|
Feed acceptability (ease of use) will be assessed at the end of week 4 by questionnaire completed by the parents/carer.
|
4 weeks
|
Nutrient intake (energy, protein and micronutrients)
Periodo de tiempo: 4 weeks
|
Nutrient intake, including the intake of all nutrition provided (including the study product, any parenteral feeding, other enteral tube feeding, foods, drinks etc) will be recorded at baseline and on Day 28 by the Dietitian using 24hour recall, and then in 3 day food diaries at baseline (Days 1, 2 and 3) and Week 4 (Days 26, 27 and 28) by the parent/carer.
A dietary analysis program will be used to calculate total dietary intake
|
4 weeks
|
Weight (kg)
Periodo de tiempo: 4 weeks
|
For safety purposes, at baseline and at the end of week 4, body weight (kg) will be measured where possible using standard methods, to the nearest 0.1kg using a weighing scale without heavy clothing.
Height will also be measured, wherever possible, using standard measures to the nearest 0.1cm.
For children up to 2yrs of age, head circumference will be measured where possible, using standard methods to the nearest 0.1cm
|
4 weeks
|
Height (cm)
Periodo de tiempo: 4 weeks
|
For safety purposes, at baseline and at the end of week 4, body weight (kg) will be measured where possible using standard methods, to the nearest 0.1kg using a weighing scale without heavy clothing.
Height will also be measured, wherever possible, using standard measures to the nearest 0.1cm.
For children up to 2yrs of age, head circumference will be measured where possible, using standard methods to the nearest 0.1cm
|
4 weeks
|
Head circumference (cm)
Periodo de tiempo: 4 weeks
|
For safety purposes, at baseline and at the end of week 4, body weight (kg) will be measured where possible using standard methods, to the nearest 0.1kg using a weighing scale without heavy clothing.
Height will also be measured, wherever possible, using standard measures to the nearest 0.1cm.
For children up to 2yrs of age, head circumference will be measured where possible, using standard methods to the nearest 0.1cm
|
4 weeks
|
Safety by Adverse Event reporting
Periodo de tiempo: 4 weeks
|
All adverse events will be recorded, throughout the study.
|
4 weeks
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- NJ002
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Amino Acid Feed
-
University of Erlangen-Nürnberg Medical SchoolDesconocidoCáncer | Desnutrición | CaquexiaAlemania
-
Florida International UniversityAcademy of Nutrition and DieteticsReclutamiento
-
Sun Yat-sen UniversityTerminado
-
Centre Hospitalier Universitaire de NiceTerminadoMiocardiopatías diabéticasFrancia
-
WayBetter, Inc.Hennepin Healthcare Research InstituteActivo, no reclutandoDejar de fumarEstados Unidos
-
University of IowaGlaxoSmithKlineTerminadoEnfermedad cardiovascularEstados Unidos
-
Merck Sharp & Dohme LLCTerminado
-
Merck Sharp & Dohme LLCTerminadoSAHA oral (ácido suberoilanilida hidroxámico) en el linfoma cutáneo avanzado de células T (0683-001)Micosis Fungoide | Síndrome de Sézary | Linfoma cutáneo de células T
-
Merck Sharp & Dohme LLCTerminado
-
Merck Sharp & Dohme LLCTerminado